Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
27.05
+0.44 (+1.65%)
Official Closing Price
Updated: 7:00 PM EST, Mar 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
53,182,256
Open
26.54
Bid (Size)
26.90 (4,700)
Ask (Size)
26.93 (200)
Prev. Close
26.61
Today's Range
26.23 - 27.13
52wk Range
20.91 - 27.94
Shares Outstanding
5,606,688,356
Dividend Yield
6.36%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Where Will Eli Lilly Stock Be in 10 Years?
↗
March 07, 2026
Eli Lilly is at the head of the pharma pack today, but in a decade, the situation could look very different.
Via
The Motley Fool
Topics
Intellectual Property
Here's Why I Wouldn't Touch Amarin With a 10‑Foot Pole Given Its Patent and Competition Risks
↗
March 07, 2026
Amarin is milking a cash cow, but it looks like that cow is slowly being bled to death.
Via
The Motley Fool
Topics
Intellectual Property
Performance
YTD
+7.4%
+7.4%
1 Month
+2.1%
+2.1%
3 Month
+5.0%
+5.0%
6 Month
+10.2%
+10.2%
1 Year
+1.2%
+1.2%
More News
Read More
Here's Why I Wouldn't Touch Regencell Bioscience With a 10‑Foot Pole Right Now
↗
March 06, 2026
Via
The Motley Fool
Argus Turns Bullish On Pfizer, Highlights GLP-1 And Oncology Pipeline
↗
March 05, 2026
Via
Talk Markets
Tariffs News & Market Chaos
↗
March 06, 2026
Via
The Motley Fool
Topics
Economy
Government
World Trade
The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology
March 06, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
China Clears Weight-Loss Shot As Pfizer Enters Crowded Market
↗
March 06, 2026
Via
Benzinga
Moderna Settles High-Stakes LNP Patent War with $2.25 Billion Agreement
March 05, 2026
Via
MarketMinute
Topics
Intellectual Property
Lawsuit
Moderna’s Renaissance: Why MRNA Surged 16% as the mRNA Platform Enters the Oncology Era
March 05, 2026
Via
Finterra
Topics
Intellectual Property
Forget Teva: This Dividend Top Dog Is the Real Value Buy Today
↗
March 04, 2026
Via
The Motley Fool
Topics
Intellectual Property
TechMediaBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Appoints Bat-Sheva Noy as Vice President of Global Sales
March 04, 2026
Via
Investor Brand Network
The Dividend Safe Harbor: 2 Stocks to Watch
↗
March 03, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead?
↗
March 03, 2026
Via
The Motley Fool
Topics
Intellectual Property
Higher Income or Ironclad Safety? VCIT vs. IEI
↗
March 03, 2026
Via
The Motley Fool
Topics
Bonds
ETFs
Viatris (VTRS): From Debt-Laden Merger to Specialty Powerhouse—A 2026 Research Deep Dive
March 03, 2026
Via
Finterra
Topics
Economy
Initial Public Offering
Retirement
Spotting Winners: Viatris (NASDAQ:VTRS) And Generic Pharmaceuticals Stocks In Q4
March 02, 2026
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
1 Reason I'd Happily Buy Pfizer (PFE) Stock and Never Sell
↗
March 02, 2026
Via
The Motley Fool
Topics
Intellectual Property
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
↗
March 01, 2026
Via
The Motley Fool
Should You Forget Eli Lilly and Buy This Magnificent High-Yield Dividend Stock Instead?
↗
March 01, 2026
Via
The Motley Fool
Topics
Intellectual Property
Here's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole
↗
February 27, 2026
Via
The Motley Fool
Topics
Intellectual Property
Big Tech’s Heavy Lifting: S&P 500 Q4 Earnings Surpass 8% Growth Amid AI Capex Anxiety
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Electric Vehicles
The Implementation Pivot: How Accenture Defied the ‘SaaS-pocalypse’ with a Massive AI Rebound
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Industrial Renaissance: Sector Surges 27% in Q4 2025 as Healthcare and Consumer Discretionary Lag
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Lilly Era: How Eli Lilly Transformed into a Trillion-Dollar Healthcare Titan
February 27, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?
February 27, 2026
Via
Barchart.com
Topics
Stocks
Frequently Asked Questions
Is Pfizer publicly traded?
Yes, Pfizer is publicly traded.
What exchange does Pfizer trade on?
Pfizer trades on the New York Stock Exchange
What is the ticker symbol for Pfizer?
The ticker symbol for Pfizer is PFE on the New York Stock Exchange
What is the current price of Pfizer?
The current price of Pfizer is 27.05
When was Pfizer last traded?
The last trade of Pfizer was at 03/06/26 07:00 PM ET
What is the market capitalization of Pfizer?
The market capitalization of Pfizer is 151.66B
How many shares of Pfizer are outstanding?
Pfizer has 152B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.